Table: Anest Iwata - 9-MTH group results
Feb 10 (Reuters)-
Anest Iwata Corp
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2020 Dec 31, 2019 Mar 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 25.51 28.20 34.50
(-9.5 pct) (-1.7 pct) (-11.7 pct)
Operating 2.47 2.85 3.00
(-13.2 pct) (-17.1 pct) (-22.6 pct)
Recurring 3.01 3.14 3.60
(-4.0 pct) (-17.2 pct) (-18.2 pct)
Net 1.94 2.01 2.10
(-3.2 pct) (-17.6 pct) (-22.7 pct)
EPS 46.75 yen 48.05 yen 50.68 yen
Ann Div 24.00 yen 24.00 yen
-Q2 div 12.00 yen 12.00 yen
-Q4 div 12.00 yen 12.00 yen
NOTE - Anest Iwata Corp.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6381.T
Recent news on Anest Iwata
See all newsBrief: Anest Iwata Corp - To Buy Back Up To 2.53% Own Shares Worth 1.5 Billion Yen
Table: Anest Iwata -2025/26 group results
Table: Anest Iwata -2025/26 parent results
Brief: China's Chery, Japan's Autobacs Seven Have Set Up JV To Sell Electric Vehicles In Japan From 2027, Nikkei Says
Table: Anest Iwata - 9-MTH group results